Scientific Publications
Presentations
Opening the Barn Door to Antibody Discovery
Presentations
Antibody Engineering & Therapeutics Conference, 2022
...
Read More
Read More
Presentations
Discovery, Expression, and Characterization of Neutralizing Picobodies against SARS-CoV2
Presentations
Antibody Engineering and Therapeutics, 2021
At 4-6 KD, “picobodies” represent the smallest known Ig-derived binding moiety capable of high affinity interactions with target proteins ...
Read More
Read More
Presentations
Chicken Heavy Chain only antibodies to SARS-CoV2
Presentations
Antibody Engineering and Therapeutics, 2021
Single domain antibodies are found naturally in camelids and sharks, and humanized versions have been engineered ...
Read More
Read More
Presentations
Antibody Discovery Powered By OmniAb
Presentations
Antibody Engineering and Therapeutics, 2021
The OmniAb platform couples cutting edge screening and data mining technologies with highly validated antibody generation systems ...
Read More
Read More
Publications
Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for...
Publications
MAbs, 2021
Bispecific antibodies are an important and growing segment in antibody therapeutics, particularly in the immuno-oncology space. Manufacturing of a bispecific ...
Read More
Read More
Presentations
xPloration®: High Throughput B Cell Profiling for Antibody Discovery from OmniAb Immune Repertoires
Presentations
2020
The success of a therapeutic antibody is directly related to its biological activity, which is a function of the epitope ...
Read More
Read More
Publications
Comparisons of the antibody repertoires of a humanized rodent and humans by high throughput sequencing
Publications
2020
The humanization of animal model immune systems by genetic engineering has shown great promise for antibody discovery, tolerance studies and ...
Read More
Read More
Publications
Expression of human lambda expands the repertoire of OmniChickens
Publications
PLOS ONE, 2020
Most of the approved monoclonal antibodies used in the clinic were initially discovered in mice. However, many targets of therapeutic ...
Read More
Read More
Presentations
OmniTaur™: Ultralong CDR3 cow antibodies for challenging targets
Presentations
2020
Bovine antibodies are unusual in having exceptionally long heavy chain CDR3 regions, with an average length of 25 amino acids, ...
Read More
Read More
Presentations
Benchmarking discovery-stage antibodies from OmniChicken (against clinical-stage antibodies from other sources)
Presentations
2019
Presentation by Bill Harriman and Shelley Izquierdo ...
Read More
Read More
